weightloss page scaled


The FDA has approved Semaglutide for the treatment of weight loss in adults. Patients who receive injections of Semaglutide for weight management feel full longer and are less hungry. This makes it easier for most people to control their cravings and overeating urges.

Semaglutide is a GLP-1 analog, which is similar to glucagon-like peptides (GLPs). The small intestine produces GLP-1. Insulin stimulates the release of blood sugar and inhibits the release of glucagon. Weekly injections of Semaglutide help to improve glycemic control and reduce appetite and food cravings.

According to doctors, this peptide is two times more effective than prescription weight loss products available today. The average weight loss for obese or overweight adults taking Semaglutide weekly was 14.9%. More than 32% of participants lost 20% or more of their initial weight while taking Semaglutide.

Book a Weight loss Consultation to see which option would be best for you!


Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor. It is a drug proposed to help treat obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

Tirzepatide is administered into the subcutaneous tissue by injections.

Tirzepatide triggers the release of insulin that blocks glucagon or the hormone that increases blood sugar levels. It also affects chemicals in the brain, which help to decrease food intake and increase energy.

The effect of Tirzepatide on blood sugar levels also helps contribute to a healthy heart and improves liver health by reducing liver fat.

Side effects may include diarrhea, nausea, vomiting, and constipation. Discuss side effect possibilities with your healthcare provider.

Favicon Roots Wellness and Medspa in Tampa, Florida.

Book an Appointment

Book your Free consultation